Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
candidates irrespective of age, gender, disability, race, religion or ethnic background are encouraged to apply. As DTU works with research in critical technology, which is subject to special rules
-
microscopy, optical interferometry, vacuum technology, finite element method simulations will be involved. Applicants should hold a PhD in Physics, Nano-science, Engineering or similar, experience with optics
-
The team you will be working with: Maxime Cordy Mike Papadakis Your profile A PhD in Computer Science, Software Engineering, Programming Languages or related disciplines. Documented research expertise in
-
in critical technology, which is subject to special rules for security and export control, open-source background checks may be conducted on qualified candidates for the position. The Department
-
Applications are invited from suitably qualified candidates for a Full time, fixed term position as a Postdoctoral Researcher with School of Natural Sciences and School of Engineering , and Ryan
-
by rigorous training on project management skills. They will have access to state-of-the-art computing for high-throughput data analysis and molecular profiling technology. Our lab has a great track
-
Temporary contract | 24 months | Belvaux Are you passionate about research? So are we! Come and join us The Luxembourg Institute of Science and Technology (LIST) is a Research and Technology
-
of research funding Your profile... The candidate should possess a PhD degree in Computer Science, Software Engineering or a related field The ideal candidate should have some knowledge and experience in
-
at Université Côte d'Azur includes 37 research teams and 8 support services. The centre's staff (about 500 people) is made up of scientists of different nationalities, engineers, technicians and administrative
-
associate to join a recently funded 5-year programme of antifungal drug discovery at the MRC Centre for Medical Mycology. This exciting new programme connects MRC CMM researchers with drug discovery experts